FDA authorization of Pfizer COVID vaccine for kids under 5 paused to wait for more data
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.